The National Institute for Health and Care Excellence

NICE publishes first quality standard to improve care for people with rare diseases

For too long, people living with rare diseases have faced uncertainty, delays, and unacceptable variation in the care they receive. The launch of this quality standard is a watershed moment. For the ...
The National Institute for Health and Care Excellence

Driving biosimilar adoption through collaboration

Looking ahead, the biosimilar taskforce will become a strategic cornerstone of the NICE Whole Lifecycle Approach programme, the 10-Year Health Plan and the drive for rapid uptake of biosimilars. This ...
The National Institute for Health and Care Excellence

More than 20,000 people benefitting from innovative migraine pills recommended by NICE

NICE recommended rimegepant in 2023 for treating migraine and preventing episodic attacks (between 4 and 14 migraines per month), and atogepant in 2024 for preventing both episodic and chronic ...
The National Institute for Health and Care Excellence

First treatment for vitiligo recommended by NICE for NHS use, bringing hope to over 80,000 people

More than 80,000 adults and teenagers across England suffering with a chronic skin condition could have their lives transformed after NICE today (Tuesday, 24 February) recommended the first licensed ...